Overexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell Line
The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
The doxorubicin-selected lung cancer cell line H69AR is resistant to many chemotherapeutic agents. However, like most tumor samples from individuals with this disease, it does not overexpress P-glycoprotein, a transmembrane transport protein that is dependent on adenosine triphosphate (ATP) and is associated with multidrug resistance. Complementary DNA (cDNA) clones corresponding to messenger RNAs (mRNAs) overexpressed in H69AR cells were isolated. One cDNA hybridized to an mRNA of 7.8 to 8.2 kilobases that was 100- to 200-fold more expressed in H69AR cells relative to drug-sensitive parental H69 cells. Overexpression was associated with amplification of the cognate gene located on chromosome 16 at band p13.1. Reversion to drug sensitivity was associated with loss of gene amplification and a marked decrease in mRNA expression. The mRNA encodes a member of the ATP-binding cassette transmembrane transporter superfamily.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The overexpression of ABCC1 in tumor cells has been implicated in the multidrug-resistant phenotype caused by cytotoxic drugs (60).”
From SRC kinase drives multidrug resistance induced by KRAS-G12C inhibition (2024) · cites this paper as [60]
In the citing paper
“ABCC1, which was originally cloned from the human small cell lung cancer cell line H69AR (60), is known to transport a variety of endogenous substrates, such as the antioxidant glutathione and pro-inflammatory leukotrienes (65).”
From SRC kinase drives multidrug resistance induced by KRAS-G12C inhibition (2024) · cites this paper as [60]
In the citing paper
“To date, at least 15 human ABC superfamily transporters, including ABCB1 (59), ABCC1 (60), and ABCG2 (61), have been reported to mediate multidrug resistance in different circumstances, including G12Ci treatment (27, 62, 63).”
From SRC kinase drives multidrug resistance induced by KRAS-G12C inhibition (2024) · cites this paper as [60]
Citations
Cites
DNA sequencing with chain-terminating inhibitors
Sanger, F., Nicklen, S., & Coulson, A. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5463 · Cited by 68,572
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity
Feinberg, A. P., & Vogelstein, B. (1983) · Analytical Biochemistry · doi:10.1016/0003-2697(83)90418-9 · Cited by 24,887
A comprehensive set of sequence analysis programs for the VAX
Devereux, J., Haeberli, P., & Smithies, O. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.1part1.387 · Cited by 14,222
Improved tools for biological sequence comparison.
Pearson, W. R., & Lipman, D. J. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.8.2444 · Cited by 11,227
Identification of the Cystic Fibrosis Gene: Cloning and Characterization of Complementary DNA
Riordan, J. R., Rommens, J. M., Kerem, B.-S., Alon, N., Rozmahel, R., Grzelczak, Z., Zielenski, J., Lok, S., Plavsic, N., Chou, J.-L., et al. (1989) · Science · doi:10.1126/science.2475911 · Cited by 7,418
Walker, J. E., Saraste, M., Runswick, M. J., & Gay, N. J. (1982) · The EMBO Journal · doi:10.1002/j.1460-2075.1982.tb01276.x · Cited by 5,312
Thiebaut, F., Tsuruo, T., Hamada, H., Gottesman, M. M., Pastan, I., & Willingham, M. C. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7735 · Cited by 2,777
Chen, C.-J., Chin, J. E., Ueda, K., Clark, D. P., Pastan, I., Gottesman, M. M., & Roninson, I. B. (1986) · Cell · doi:10.1016/0092-8674(86)90595-7 · Cited by 1,898
Progressive sequence alignment as a prerequisitetto correct phylogenetic trees
Feng, D.-F., & Doolittle, R. F. (1987) · Journal of Molecular Evolution · doi:10.1007/bf02603120 · Cited by 1,883
Cordon-Cardo, C., O'Brien, J. P., Casals, D., Rittman-Grauer, L., Biedler, J. L., Melamed, M. R., & Bertino, J. R. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.2.695 · Cited by 1,750
Research works printed but not linked: 3
- GERLACH, J.H., MULTIDRUG RESISTANCE, CANCER SURVEYS 5: 25 (1986).
- UEYAMA, H, STRUCTURE OF A HUMAN SMOOTH-MUSCLE ACTIN GENE (AORTIC TYPE) WITH A UNIQUE INTRON SITE, MOLECULAR AND CELLULAR BIOLOGY 4: 1073 (1984).
- VANDERBLIEK, A.M., OVEREXPRESSION AND AMPLIFICATION OF 5 GENES IN A MULTIDRUG-RESISTANT CHINESE-HAMSTER OVARY CELL-LINE, MOLECULAR AND CELLULAR BIOLOGY 6: 1671 (1986).
Cited by
Items 301–400 of 1,012
Ahmed-Belkacem, A., Pozza, A., Muñoz-Martínez, F., Bates, S. E., Castanys, S., Gamarro, F., Di Pietro, A., & Pérez-Victoria, J. M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-1817 · Cited by 196
Detergent-free purification of ABC (ATP-binding-cassette) transporters
Gulati, S., Jamshad, M., Knowles, T. J., Morrison, K. A., Downing, R., Cant, N., Collins, R., Koenderink, J. B., Ford, R. C., Overduin, M., et al. (2014) · Biochemical Journal · doi:10.1042/bj20131477 · Cited by 195
pH and drug resistance in tumors
Raghunand, N., & Gillies, R. J. (2000) · Drug Resistance Updates · doi:10.1054/drup.2000.0119 · Cited by 194
“Classical multidrug resistance is associated with the overexpresion of drug pumps like P-glycoprotein (P-gp), a 170–180 kD plasma membrane glycoprotein(60) or the multidrug resistance-associated protein (MRP) which has been cloned from a multidrug resistant, doxorubicin-selected cell line that did not overexpress P-gl…”
BackgroundMaher, J. M., Slitt, A. L., Cherrington, N. J., Cheng, X., & Klaassen, C. D. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.003780 · Cited by 195
“Since the discovery of MRP1 in 1992 (Cole et al., 1992), eight additional human MRPs have been cloned.”
BackgroundAllen, J. D., & Schinkel, A. H. (2002) · PubMed · Cited by 218
Transport properties of the multidrug resistance‐associated protein (MRP) in human tumour cells
Holló, Z., Homolya, L., Hegedüs, T., & Sarkadi, B. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)00237-2 · Cited by 195
P-glycoprotein, multidrug resistance and tumor progression
Bradley, G., & Ling, V. (1994) · Cancer and Metastasis Reviews · doi:10.1007/bf00689638 · Cited by 195
Loe, D. W., Stewart, R. K., Massey, T. E., Deeley, R. G., & Cole, S. P. C. (1997) · Molecular Pharmacology · doi:10.1124/mol.51.6.1034 · Cited by 195
“In contrast, MRP is expressed at very low levels in the liver but at relatively high levels in the lung (10, 40, 41), which may indicate a more significant role for MRP in pulmonary GSH S-conjugate export.”
BackgroundResultSelf-citationHallstrom, T. C., & Moye-Rowley, W. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m007338200 · Cited by 194
Feller, N., Broxterman, H. J., Währer, D. C. R., & Pinedo, H. M. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00677-2 · Cited by 192
Calcabrini, A., Stringaro, A., Toccacieli, L., Meschini, S., Marra, M., Colone, M., Arancia, G., Molinari, A., Salvatore, G., & Mondello, F. (2004) · Journal of Investigative Dermatology · doi:10.1046/j.0022-202x.2004.22236.x · Cited by 190
“Several studies suggest that a class of specific drug-transporter proteins, including P-glycoprotein (P-gp) (Berger et al, 1994; Alvarez et al, 1995; Molinari et al, 1998, 2000) and MDRrelated protein (MRP1) (Cole et al, 1992), might play a central part in the establishment of the MDR phenotype in melanoma cells.”
BackgroundPaumi, C. M., Chuk, M., Snider, J., Stagljar, I., & Michaelis, S. (2009) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00020-09 · Cited by 190
“overexpressed in a human cancer-derived cell line, to confer multidrug resistance to a variety of chemotherapeutic cancer drugs (21).”
BackgroundThe human ATP‐binding cassette (ABC) transporter superfamily
Dean, M., Moitra, K., & Allikmets, R. (2022) · Human Mutation · doi:10.1002/humu.24418 · Cited by 187
“The ABCC1/MRP1 gene encodes a multidrug resistance protein (Cole et al., 1992).”
BackgroundWong, N., Yeo, W., Wong, W., Wong, N. L. ‐., Chan, K. Y. ‐., Mo, F. K. ‐., Koh, J., Chan, S. L., Chan, A. T. ‐., Lai, P. B. ‐., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.23968 · Cited by 190
Subcellular Localization and Activity of Multidrug Resistance Proteins
Rajagopal, A., & Simon, S. M. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-11-0704 · Cited by 190
“…protein 1 (MRP1), and breast cancer resistance protein (BCRP), for example, have each been cloned from a drug-resistant cancer line and are thought to mediate drug efflux from the cell at the plasma membrane (Kartner et al., 1983; Cole et al., 1992; Doyle et al., 1998; Maliepaard et al., 2001).”
BackgroundExpression of the multidrug resistance proteins MRP2 and MRP3 in human hepatocellular carcinoma
Nies, A. T., König, J., Pfannschmidt, M., Klar, E., Hofmann, W. J., & Keppler, D. (2001) · International Journal of Cancer · doi:10.1002/ijc.1498 · Cited by 189
Grondin, K. (1997) · The EMBO Journal · doi:10.1093/emboj/16.11.3057 · Cited by 188
“One is the multidrug resistance-associated pro- tein MRP (Cole et al., 1992), a distant homolog of PgpA Nevertheless, cisplatin was found recently to induce the human MRP and γ-GCS genes coordinately (Ishikawawhich was shown to transport GSH-linked substrates (Leier et al., 1994; Müller et al., 1994).”
BackgroundInfluentialTransport of Bile Acids in Hepatic and Non-Hepatic Tissues
St-Pierre, M. V., Kullak-Ublick, G. A., Hagenbuch, B., & Meier, P. J. (2001) · Journal of Experimental Biology · doi:10.1242/jeb.204.10.1673 · Cited by 186
Izquierdo, M. A., Scheffer, G. L., Flens, M. J., Giaccone, G., Broxterman, H. J., Meijer, C. J. L. M., van der Valk, P., & Scheper, R. J. (1996) · Europe PMC (PubMed Central) · Cited by 186
Multidrug Resistance and the Lung Resistance-Related Protein in Human Colon Carcinoma SW-620 Cells
Kitazono, M., Sumizawa, T., Takebayashi, Y., Chen, Z.-S., Furukawa, T., Nagayama, S., Tani, A., Takao, S., Aikou, T., & Akiyama, S.-I. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.19.1647 · Cited by 186
Minich, T., Riemer, J., Schulz, J. B., Wielinga, P., Wijnholds, J., & Dringen, R. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03737.x · Cited by 185
“Their function was first described in the resistance of tumour cells against chemotherapeutical drugs (Cole et al. 1992).”
BackgroundOrelle, C., Dalmas, O., Gros, P., Di Pietro, A., & Jault, J.-M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308268200 · Cited by 184
Strazielle, N., & Ghersi-Egea, J.-F. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-15-06275.1999 · Cited by 184
“Six members of this family, exhibiting different tissue distribution and intracellular localization, have been identified to date (Cole et al., 1992; Büchler et al., 1996; Paulusma et al., 1996; Ito et al., 1997; Kool et al., 1997; Kiuchi et al., 1998; Uchiumi et al., 1998; Kool et al., 1999).”
BackgroundFan, J., To, K. K. W., Chen, Z.-S., & Fu, L. (2023) · Drug Resistance Updates · doi:10.1016/j.drup.2022.100905 · Cited by 180
Kamisako, T., Leier, I., Cui, Y., König, J., Buchholz, U., Hummel-Eisenbeiss, J., & Keppler, D. (1999) · Hepatology · doi:10.1002/hep.510300220 · Cited by 184
An oncological view on the blood–testis barrier
Bart, J., Groen, H. J., van der Graaf, W. T., Hollema, H., Hendrikse, N. H., Vaalburg, W., Sleijfer, D. T., & de Vries, E. G. (2002) · The Lancet Oncology · doi:10.1016/s1470-2045(02)00776-3 · Cited by 183
MDR- and CYP3A4-Mediated Drug–Drug Interactions
Pal, D., & Mitra, A. K. (2006) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-006-9034-2 · Cited by 181
The role of ABC transporters in ovarian cancer progression and chemoresistance
Ween, M. P., Armstrong, M. A., Oehler, M. K., & Ricciardelli, C. (2015) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2015.05.012 · Cited by 181
Portrait of multifaceted transporter, the multidrug resistance-associated protein 1 (MRP1/ABCC1)
Bakos, É., & Homolya, L. (2007) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-006-0160-8 · Cited by 177
ABCG2 overexpression in colon cancer cells resistant to SN38 and in irinotecan‐treated metastases
Candeil, L., Gourdier, I., Peyron, D., Vezzio, N., Copois, V., Bibeau, F., Orsetti, B., Scheffer, G. L., Ychou, M., Khan, Q. A., et al. (2004) · International Journal of Cancer · doi:10.1002/ijc.20032 · Cited by 180
The blood-brain barrier and oncology: new insights into function and modulation
Bart, J., Groen, H. J. M., Hendrikse, N. H., van der Graaf, W. T. A., Vaalburg, W., & de Vries, E. G. E. (2000) · Cancer Treatment Reviews · doi:10.1053/ctrv.2000.0194 · Cited by 179
Natural alkaloids as P-gp inhibitors for multidrug resistance reversal in cancer
Joshi, P., Vishwakarma, R. A., & Bharate, S. B. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.06.047 · Cited by 174
Hinoshita, E., Uchiumi, T., Taguchi, K., Kinukawa, N., Tsuneyoshi, M., Maehara, Y., Sugimachi, K., & Kuwano, M. (2000) · PubMed · Cited by 179
van Zanden, J. J., Wortelboer, H. M., Bijlsma, S., Punt, A., Usta, M., Bladeren, P. J. V., Rietjens, I. M. C. M., & Cnubben, N. H. P. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.11.002 · Cited by 178
Dantzig, A. H., Shepard, R. L., Law, K. L., Tabas, L., Pratt, S., Gillespie, J. S., Binkley, S. N., Kuhfeld, M. T., Starling, J. J., & Wrighton, S. A. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)34974-2 · Cited by 179
“MDR also can result from the overexpression of MRP1, another member of the ABC transporter family (Cole et al., 1992).”
ATP Binding Enables Substrate Release from Multidrug Resistance Protein 1
Johnson, Z. L., & Chen, J. (2018) · Cell · doi:10.1016/j.cell.2017.12.005 · Cited by 179
“The biochemical and pharmacological properties of MRP1 have been extensively studied since its discovery in 1992 (Cole et al., 1992; Cole 2014b).”
The Mechanism of Action of Multidrug-Resistance-Linked P-Glycoprotein
Sauna, Z. E., Smith, M. M., Müller, M., Kerr, K. M., & Ambudkar, S. V. (2001) · Journal of Bioenergetics and Biomembranes · doi:10.1023/a:1012875105006 · Cited by 178
Legrand, O., Simonin, G., Beauchamp-Nicoud, A., Zittoun, R., & Marie, J.-P. (1999) · Blood · doi:10.1182/blood.v94.3.1046.415k03_1046_1056 · Cited by 179
“The rate of (1) relapse-free survival (RFS) was measured from establishment of complete remission (CR) until relapse or death from any cause, with observation censored for patients last known alive without report of relapse; and (2) overall survival (OS) was measured from diagnosis until death from any cause, with obs…”
MethodChen, Z.-S., Kawabe, T., Ono, M., Aoki, S., Sumizawa, T., Furukawa, T., Uchiumi, T., Wada, M., Kuwano, M., & Akiyama, S.-I. (1999) · Molecular Pharmacology · doi:10.1124/mol.56.6.1219 · Cited by 178
“cassette transporter (Cole et al., 1992), was found in many”
Topoisomerase Inhibitors: A Review of their Therapeutic Potential in Cancer
Sinha, B. K. (1995) · Drugs · doi:10.2165/00003495-199549010-00002 · Cited by 178
Analysis of the structure and expression pattern of MRP7 (ABCC10), a new member of the MRP subfamily
Hopper, E., Belinsky, M. G., Zeng, H., Tosolini, A., Testa, J. R., & Kruh, G. D. (2001) · Cancer Letters · doi:10.1016/s0304-3835(00)00646-7 · Cited by 178
Voltage-gated calcium channels: Novel targets for cancer therapy
Phan, N. N., Wang, C.-Y., Chen, C.-F., Sun, Z., Lai, M.-D., & Lin, Y.-C. (2017) · Oncology Letters · doi:10.3892/ol.2017.6457 · Cited by 176
“Expression levels of genes are currently recognized as potential biological markers (29-32).”
BackgroundClinical multidrug resistance in cancer: A multifactorial problem
Lehnert, M. (1996) · European Journal of Cancer · doi:10.1016/0959-8049(96)00069-x · Cited by 176
Gao, M., Cui, H.-R., Loe, D. W., Grant, C. E., Almquist, K. C., Cole, S. P. C., & Deeley, R. G. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.17.13098 · Cited by 175
Self-citationDenk, G. U., Soroka, C. J., Takeyama, Y., Chen, W.-S., Schuetz, J. D., & Boyer, J. L. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2003.12.001 · Cited by 147
MRP subfamily ABC transporters from plants and yeast
Rea, P. (1999) · Journal of Experimental Botany · doi:10.1093/jexbot/50.suppl_1.895 · Cited by 174
Blood–Brain Barrier Efflux Transport
Golden, P. L., & Pollack, G. M. (2003) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10424 · Cited by 174
Expression of the multidrug resistance-associated protein (MRP) gene in human cancers.
Nooter, K., Westerman, A. M., Flens, M. J., Zaman, G. J., Scheper, R. J., van Wingerden, K. E., Burger, H., Oostrum, R. G., Boersma, T., & Sonneveld, P. (1995) · PubMed · Cited by 210
ATP-dependent para-aminohippurate transport by apical multidrug resistance protein MRP2
Leier, I., Hummel-Eisenbeiss, J., Cui, Y., & Keppler, D. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00007.x · Cited by 173
Zeng, H., Bain, L. J., Belinsky, M. G., & Kruh, G. D. (1999) · PubMed · Cited by 186
Molecular Mechanisms of Multidrug Resistance in Cancer Chemotherapy
Nooter, K., & Stoter, G. (1996) · Pathology - Research and Practice · doi:10.1016/s0344-0338(96)80099-9 · Cited by 171
Regev, R., Assaraf, & Eytan, G. D. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00037.x · Cited by 171
MRP Subfamily Transporters and Resistance to Anticancer Agents
Kruh, G. D., Zeng, H., Rea, P. A., Liu, G., Chen, Z.-S., Lee, K., & Belinsky, M. G. (2001) · Journal of Bioenergetics and Biomembranes · doi:10.1023/a:1012827221844 · Cited by 170
Belinsky, M. G., Bain, L. J., Balsara, B. B., Testa, J. R., & Kruh, G. D. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.22.1735 · Cited by 170
Minderman, H., O’Loughlin, K. L., Pendyala, L., & Baer, M. R. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0914-3 · Cited by 170
“MRP-1 is structurally similar to Pgp but shares only 15% amino acid sequence identity (3); it also confers resistance to anthracyclines, mitoxantrone, and epipodophyllotoxins but differs from Pgp in the level of resistance to taxanes (5, 6).”
BackgroundMolecular pharmacology of renal organic anion transporters
Van Aubel, R. A. M. H., Masereeuw, R., & Russel, F. G. M. (2000) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2000.279.2.f216 · Cited by 170
Borst, P., Schinkel, A. H., Smit, J. J. M., Wagenaar, E., Van Deemter, L., Smith, A. J., Eijdems, E. W. H. M., Baas, F., & Zaman, G. J. R. (1993) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(93)90011-2 · Cited by 170
Resistance to Chemotherapy in Cancer: A Complex and Integrated Cellular Response
Mellor, H. R., & Callaghan, R. (2008) · Pharmacology · doi:10.1159/000115967 · Cited by 168
“Two further members of the ABC superfamily of transporters have been implicated as multidrug efflux pumps capable of conferring resistance to chemotherapy. The multidrug-resistance-associated protein (MRP1), also an ABC transporter, was discovered in resistant lung cancer cells [”
BackgroundLeveraging Physiology for Precision Drug Delivery
Sun, W., Hu, Q., Ji, W., Wright, G., & Gu, Z. (2017) · Physiological Reviews · doi:10.1152/physrev.00015.2016 · Cited by 169
Yan, J., Dang, Y., Liu, S., Zhang, Y., & Zhang, G. (2016) · Tumor Biology · doi:10.1007/s13277-016-5448-5 · Cited by 168
“Multidrug resistance-associated protein 1 (MRP1) is a member of the ATP-binding cassette (ABC) transporter superfamily that can be classified into seven distinct subfamilies and functions as multispecific organic anion transporters, while MRP1 involves in cisplatin-induced multidrug resistance [32, 33].”
BackgroundImmunohistochemical Localization of Multispecific Renal Organic Anion Transporter 1 in Rat Kidney
TOJO, A., SEKINE, T., NAKAJIMA, N., HOSOYAMADA, M., KANAI, Y., KIMURA, K., & ENDOU, H. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v103464 · Cited by 171
Tyrosine kinase inhibitors as modulators of ABC transporter-mediated drug resistance
Shukla, S., Chen, Z.-S., & Ambudkar, S. V. (2012) · Drug Resistance Updates · doi:10.1016/j.drup.2012.01.005 · Cited by 168
“They include P-gp (MDR1/ABCB1) (Juliano and Ling, 1976), Multidrug Resistance Proteins (MRPs) 1, 2, 3, 4, 5, 6, 7, and 8 ((Cole et al., 1992), reviewed in (Borst et al.”
BackgroundInfluentialCellular resistance to anthracyclines
Nielsen, D., Maare, C., & Skovsgaard, T. (1996) · General Pharmacology: The Vascular System · doi:10.1016/0306-3623(95)02013-6 · Cited by 167
Young, L. C., Campling, B. G., Voskoglou-Nomikos, T., Cole, S. P. C., Deeley, R. G., & Gerlach, J. H. (1999) · PubMed · Cited by 168
Self-citationRole of ABC transporters in cancer chemotherapy
Sun, Y.-L., Patel, A., Kumar, P., & Chen, Z.-S. (2012) · Chinese Journal of Cancer · doi:10.5732/cjc.011.10466 · Cited by 166
Drug Resistance in Metastatic Breast Cancer: Tumor Targeted Nanomedicine to the Rescue
Gote, V., Nookala, A. R., Bolla, P. K., & Pal, D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094673 · Cited by 166
“This transporter was first discovered while studying the H69AR cell line, which is a small cell lung cancer drug-resistant line [50,51].”
BackgroundLeslie, E. M., Ito, K.-I., Upadhyaya, P., Hecht, S. S., Deeley, R. G., & Cole, S. P. C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102453200 · Cited by 167
Self-citationTommasini, R., Evers, R., Vogt, E., Mornet, C., Zaman, G. J., Schinkel, A. H., Borst, P., & Martinoia, E. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.13.6743 · Cited by 167
Innovative nano-carriers in anticancer drug delivery-a comprehensive review
Dong, P., Rakesh, K. P., Manukumar, H. M., Mohammed, Y. H. E., Karthik, C. S., Sumathi, S., Mallu, P., & Qin, H.-L. (2019) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2019.01.019 · Cited by 166
Ito, K.-I., Olsen, S. L., Qiu, W., Deeley, R. G., & Cole, S. P. C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011246200 · Cited by 166
Self-citationPaclitaxel And Docetaxel Resistance: Molecular Mechanisms and Development of New Generation Taxanes
Galletti, E., Magnani, M., Renzulli, M. L., & Botta, M. (2007) · ChemMedChem · doi:10.1002/cmdc.200600308 · Cited by 164
Yamane, Y., Furuichi, M., Song, R., Van, N. T., Mulcahy, R. T., Ishikawa, T., & Kuo, M. T. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.47.31075 · Cited by 165
Recurrent WNT pathway alterations are frequent in relapsed small cell lung cancer
Wagner, A. H., Devarakonda, S., Skidmore, Z. L., Krysiak, K., Ramu, A., Trani, L., Kunisaki, J., Masood, A., Waqar, S. N., Spies, N. C., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06162-9 · Cited by 163
Glutathione Stimulates Sulfated Estrogen Transport by Multidrug Resistance Protein 1
Qian, Y.-M., Song, W.-C., Cui, H., Cole, S. P. C., & Deeley, R. G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008251200 · Cited by 164
Self-citationThe medicinal chemistry of multidrug resistance (MDR) reversing drugs
Teodori, E., Dei, S., Scapecchi, S., & Gualtieri, F. (2002) · Il Farmaco · doi:10.1016/s0014-827x(02)01229-6 · Cited by 164
Egashira, M., Kawamata, N., Sugimoto, K., Kaneko, T., & Oshimi, K. (1999) · Blood · doi:10.1182/blood.v93.2.599 · Cited by 163
ATP-binding cassette efflux transporters and MDR in cancer
Pote, M. S., & Gacche, R. N. (2023) · Drug Discovery Today · doi:10.1016/j.drudis.2023.103537 · Cited by 161
The ABC family of multidrug transporters in microorganisms
van Veen, H. W., & Konings, W. N. (1998) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(98)00039-5 · Cited by 162
Chapuy, B., Koch, R., Radunski, U., Corsham, S., Cheong, N., Inagaki, N., Ban, N., Wenzel, D., Reinhardt, D., Zapf, A., et al. (2008) · Leukemia · doi:10.1038/leu.2008.103 · Cited by 162
“These transporters are located in the plasma membrane, thus making reductions in total cell drug retention a conceivable explanation for the resistant phenotype”
BackgroundPseudoxanthoma elasticum: a clinical, histopathological, and molecular update
Hu, X., Plomp, A. S., van Soest, S., Wijnholds, J., de Jong, P. T. V. M., & Bergen, A. A. B. (2003) · Survey of Ophthalmology · doi:10.1016/s0039-6257(03)00053-5 · Cited by 164
The Structure of the Multidrug Resistance Protein 1 (MRP1/ABCC1)
Rosenberg, M. F., Mao, Q., Holzenburg, A., Ford, R. C., Deeley, R. G., & Cole, S. P. C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100176200 · Cited by 161
Self-citationVisualization of multidrug resistance in vivo
Hendrikse, N. H., Franssen, E. J. F., van der Graaf, W. T. A., Vaalburg, W., & de Vries, E. G. E. (1999) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590050390 · Cited by 161
“in a doxorubicin-resistant small cell lung carcinoma cell line (SCLC) as a member of the ATP-binding cassette superfamily [25].”
ABC transporters in fish species: a review
Ferreira, M., Costa, J., & Reis-Henriques, M. A. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00266 · Cited by 160
“After the discovery of ABCB1, the study on cancer cells displaying MDR phenotype not associated with ABCB1 expression, led to the discovery of ABCC1, the founding member of the ABCC subfamily (Cole et al., 1992).”
BackgroundMbaveng, A. T., Kuete, V., & Efferth, T. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00343 · Cited by 162
“Additionally, other ABC transporters such as ABCC1/MRP1 (Cole et al., 1992) and ABCG2 (Kim et al., 2002) are also overexpressed in cancer cells and could be targeted by plant products.”
BackgroundKim, M., Cooper, D. D., Hayes, S. F., & Spangrude, G. J. (1998) · Blood · doi:10.1182/blood.v91.11.4106 · Cited by 159
Lu, C., & Shervington, A. (2008) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-008-9722-8 · Cited by 159
“MRP1 was first discovered in human small cell lung cancer cell line (H69AR) selectively resistant to anthracycline [19] and has been associated with MDR in gliomas.”
BackgroundNrf2 Pathway Regulates Multidrug-Resistance-Associated Protein 1 in Small Cell Lung Cancer
Ji, L., Li, H., Gao, P., Shang, G., Zhang, D. D., Zhang, N., & Jiang, T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063404 · Cited by 158
“cloned highly over-expressed in a doxorubicin-selected multidrug resistant human lung carcinoma cell line H69AR [4].”
BackgroundVerapamil Stimulates Glutathione Transport by the 190-kDa Multidrug Resistance Protein 1 (MRP1)
Loe, D. W., Deeley, R. G., & Cole, S. P. C. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39265-1 · Cited by 159
“Both MRP1 and P-glycoprotein are members of the ATPbinding cassette (ABC) superfamily of transport proteins but share ,20% amino acid identity (Cole et al., 1992).”
Self-citationRobey, R. W., Shukla, S., Finley, E. M., Oldham, R. K., Barnett, D., Ambudkar, S. V., Fojo, T., & Bates, S. E. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.12.001 · Cited by 158
“[4] Cole SPC, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC, et al.”
BackgroundChamberlain, L. J., Yannas, I. V., Hsu, H.-P., Strichartz, G. R., & Spector, M. (2000) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(20000601)60:5<666::aid-jnr12>3.0.co;2-0 · Cited by 159
Gao, M., Loe, D. W., Grant, C. E., Cole, S. P. C., & Deeley, R. G. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.44.27782 · Cited by 159
Self-citationDalton, W. S., Crowley, J. J., Salmon, S., Grogan, T. M., Laufman, L. R., Weiss, G. R., & Bonnet, J. D. (1995) · Cancer · doi:10.1002/1097-0142(19950201)75:3<865::aid-cncr2820750319>3.0.co;2-z · Cited by 157
Advani, R., Saba, H. I., Tallman, M. S., Rowe, J. M., Wiernik, P. H., Ramek, J., Dugan, K., Lum, B., Villena, J., Davis, E., et al. (1999) · Blood · doi:10.1182/blood.v93.3.787 · Cited by 158
“8 PSC 833 inhibitable 49 (27-96)* 95 (16-98)†”
Molecular Basis for K ATP Assembly
Schwappach, B., Zerangue, N., Jan, Y. N., & Jan, L. Y. (2000) · Neuron · doi:10.1016/s0896-6273(00)81146-0 · Cited by 166
“, MRP1HA (Figure 2C) ,”
Characterization of the ATP‐dependent leukotriene C4 export carrier in mastocytoma cells
LEIER, I., JEDLITSCHKY, G., BUCHHOLZ, U., & KEPPLER, D. (1994) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1994.tb18661.x · Cited by 157
Aging and Cancer: Issues of Basic and Clinical Science
Ershler, W. B., & Longo, D. L. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.20.1489 · Cited by 156
Inhibitors of glutathione S-transferases as therapeutic agents
Schultz, M., Dutta, S., & Tew, K. D. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00029-x · Cited by 155
Raggers, R. J., van Helvoort, A., Evers, R., & Gerrit van, M. E. E. R. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.3.415 · Cited by 164
Mammalian P4-ATPases and ABC transporters and their role in phospholipid transport
Coleman, J. A., Quazi, F., & Molday, R. S. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2012.10.006 · Cited by 154
Glyoxalase I is involved in resistance of human leukemia cells to antitumor agent-induced apoptosis
Sakamoto, H., Mashima, T., Kizaki, A., Dan, S., Hashimoto, Y., Naito, M., & Tsuruo, T. (2000) · Blood · doi:10.1182/blood.v95.10.3214 · Cited by 154
Metadata
- Authors
- Cole, S. P. C., Bhardwaj, G., Gerlach, J. H., Mackie, J. E., Grant, C. E., Almquist, K. C., Stewart, A. J., Kurz, E. U., Duncan, A. M. V., & Deeley, R. G.
- Affiliations
- Queen's University (CA)
- Venue
- Science
- Published
- 1992-12-04
- Volume
- 258
- Issue
- 5088
- Pages
- 1650-1654
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2168070336
- Cited by
- 3,037
- References
- 47
- Citations by year
- 2026: 12 · 2025: 30 · 2024: 46 · 2023: 55 · 2022: 40 · 2021: 53 · 2020: 61 · 2019: 39 · 2018: 45 · 2017: 55 · 2016: 66 · 2015: 67 · 2014: 79 · 2013: 80 · 2012: 77
- FWCI
- 37.07
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Keywords
- multidrug resistance, lung cancer, doxorubicin resistance, ABC transporters, gene amplification, P-glycoprotein, mRNA overexpression, cDNA cloning
- MeSH terms
- Amino Acid Sequence, Animals, Chromosome Banding, Chromosomes, Human, Pair 16, Doxorubicin, Drug Resistance, Gene Amplification, Multigene Family, Humans, Lung, Lung Neoplasms, Male, Membrane Glycoproteins, Molecular Sequence Data, Phylogeny, RNA, Messenger, Testis, Tumor Cells, Cultured, Sequence Homology, Amino Acid, ATP Binding Cassette Transporter, Subfamily B, Member 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.